rs35251510

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BS1BS2

The NM_003888.4(ALDH1A2):​c.1254C>A​(p.Ile418Ile) variant causes a splice region, synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00301 in 1,613,738 control chromosomes in the GnomAD database, including 75 homozygotes. In-silico tool predicts a benign outcome for this variant. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0063 ( 8 hom., cov: 32)
Exomes 𝑓: 0.0027 ( 67 hom. )

Consequence

ALDH1A2
NM_003888.4 splice_region, synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 1.99

Publications

5 publications found
Variant links:
Genes affected
ALDH1A2 (HGNC:15472): (aldehyde dehydrogenase 1 family member A2) This protein belongs to the aldehyde dehydrogenase family of proteins. The product of this gene is an enzyme that catalyzes the synthesis of retinoic acid (RA) from retinaldehyde. Retinoic acid, the active derivative of vitamin A (retinol), is a hormonal signaling molecule that functions in developing and adult tissues. The studies of a similar mouse gene suggest that this enzyme and the cytochrome CYP26A1, concurrently establish local embryonic retinoic acid levels which facilitate posterior organ development and prevent spina bifida. Four transcript variants encoding distinct isoforms have been identified for this gene. [provided by RefSeq, May 2011]
ALDH1A2 Gene-Disease associations (from GenCC):
  • diaphragmatic hernia 4, with cardiovascular defects
    Inheritance: AR Classification: STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.28).
BP6
Variant 15-57961292-G-T is Benign according to our data. Variant chr15-57961292-G-T is described in ClinVar as Benign. ClinVar VariationId is 779960.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=1.99 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00633 (964/152262) while in subpopulation AFR AF = 0.0164 (682/41536). AF 95% confidence interval is 0.0154. There are 8 homozygotes in GnomAd4. There are 442 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 8 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ALDH1A2NM_003888.4 linkc.1254C>A p.Ile418Ile splice_region_variant, synonymous_variant Exon 11 of 13 ENST00000249750.9 NP_003879.2
ALDH1A2NM_001206897.2 linkc.1191C>A p.Ile397Ile splice_region_variant, synonymous_variant Exon 12 of 14 NP_001193826.1
ALDH1A2NM_170696.3 linkc.1140C>A p.Ile380Ile splice_region_variant, synonymous_variant Exon 10 of 12 NP_733797.1
ALDH1A2NM_170697.3 linkc.966C>A p.Ile322Ile splice_region_variant, synonymous_variant Exon 9 of 11 NP_733798.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ALDH1A2ENST00000249750.9 linkc.1254C>A p.Ile418Ile splice_region_variant, synonymous_variant Exon 11 of 13 1 NM_003888.4 ENSP00000249750.4

Frequencies

GnomAD3 genomes
AF:
0.00632
AC:
961
AN:
152144
Hom.:
8
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0164
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00425
Gnomad ASJ
AF:
0.00231
Gnomad EAS
AF:
0.0121
Gnomad SAS
AF:
0.000829
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.0159
Gnomad NFE
AF:
0.00175
Gnomad OTH
AF:
0.00907
GnomAD2 exomes
AF:
0.00253
AC:
634
AN:
250782
AF XY:
0.00214
show subpopulations
Gnomad AFR exome
AF:
0.0157
Gnomad AMR exome
AF:
0.00272
Gnomad ASJ exome
AF:
0.00258
Gnomad EAS exome
AF:
0.00245
Gnomad FIN exome
AF:
0.000233
Gnomad NFE exome
AF:
0.00157
Gnomad OTH exome
AF:
0.00311
GnomAD4 exome
AF:
0.00267
AC:
3898
AN:
1461476
Hom.:
67
Cov.:
32
AF XY:
0.00256
AC XY:
1860
AN XY:
727088
show subpopulations
African (AFR)
AF:
0.0198
AC:
664
AN:
33476
American (AMR)
AF:
0.00335
AC:
150
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.00207
AC:
54
AN:
26132
East Asian (EAS)
AF:
0.0337
AC:
1336
AN:
39692
South Asian (SAS)
AF:
0.000533
AC:
46
AN:
86244
European-Finnish (FIN)
AF:
0.0000753
AC:
4
AN:
53134
Middle Eastern (MID)
AF:
0.0160
AC:
92
AN:
5760
European-Non Finnish (NFE)
AF:
0.00118
AC:
1312
AN:
1111934
Other (OTH)
AF:
0.00397
AC:
240
AN:
60384
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.466
Heterozygous variant carriers
0
202
404
606
808
1010
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
64
128
192
256
320
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00633
AC:
964
AN:
152262
Hom.:
8
Cov.:
32
AF XY:
0.00594
AC XY:
442
AN XY:
74438
show subpopulations
African (AFR)
AF:
0.0164
AC:
682
AN:
41536
American (AMR)
AF:
0.00425
AC:
65
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.00231
AC:
8
AN:
3470
East Asian (EAS)
AF:
0.0121
AC:
63
AN:
5188
South Asian (SAS)
AF:
0.000830
AC:
4
AN:
4820
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10606
Middle Eastern (MID)
AF:
0.0137
AC:
4
AN:
292
European-Non Finnish (NFE)
AF:
0.00175
AC:
119
AN:
68024
Other (OTH)
AF:
0.00898
AC:
19
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
49
98
147
196
245
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00394
Hom.:
7
Bravo
AF:
0.00688
Asia WGS
AF:
0.00895
AC:
31
AN:
3478
EpiCase
AF:
0.00278
EpiControl
AF:
0.00202

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Dec 31, 2019
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

ALDH1A2-related disorder Benign:1
Feb 22, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.28
CADD
Benign
13
DANN
Benign
0.89
PhyloP100
2.0
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=88/12
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs35251510; hg19: chr15-58253490; API